Validation of Synthetic CRISPR Reagents as a Tool for Arrayed Functional Genomic Screening

To date, lentiviral-based CRISPR-Cas9 screens have largely been conducted in pooled format. However, numerous assays are not amenable to pooled approaches, and lentiviral screening in arrayed format presents many challenges. We sought to examine synthetic CRISPR reagents in the context of arrayed screening. Experiments were performed using aberrant DNA replication as an assay. Using synthetic CRISPR RNAs targeting the known control gene GMNN in HCT-116 cells stably expressing Cas9, we observed statistically significant phenotype among the majority of transfected cells within 72 hours. Additional studies revealed near complete loss of GMNN protein and editing of GMNN DNA. We next conducted a screen of synthetic CRISPR RNAs directed against 640 ubiquitin-related genes. Screening identified known and novel DNA replication regulators that were also supported by siRNA gene knockdown. Notably, CRISPR screening identified more statistically significant hits than corresponding siRNA screens run in parallel. These results highlight the possibility of using synthetic CRISPR reagents as an arrayed screening tool.

[1]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[2]  John A. Tallarico,et al.  Functional CRISPR screening identifies the ufmylation pathway as a regulator of SQSTM1/p62 , 2016, eLife.

[3]  Nevan J Krogan,et al.  A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells. , 2016, Cell reports.

[4]  E. Lander,et al.  Genetic Screens in Human Cells Using the CRISPR-Cas9 System , 2013, Science.

[5]  Neville E. Sanjana,et al.  Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells , 2014, Science.

[6]  L. Lum,et al.  Computational detection and suppression of sequence-specific off-target phenotypes from whole genome RNAi screens , 2014, Nucleic acids research.

[7]  Oleg Mayba,et al.  CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. , 2016, The Journal of clinical investigation.

[8]  John A. Tallarico,et al.  Tankyrase Inhibitor Sensitizes Lung Cancer Cells to Endothelial Growth Factor Receptor (EGFR) Inhibition via Stabilizing Angiomotins and Inhibiting YAP Signaling* , 2016, The Journal of Biological Chemistry.

[9]  Antoine M. van Oijen,et al.  Real-time single-molecule observation of rolling-circle DNA replication , 2009, Nucleic acids research.

[10]  Joshua E. Elias,et al.  Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens , 2016, Nature.

[11]  Yuanzhong Wu,et al.  A genome-scale CRISPR-Cas9 screening method for protein stability reveals novel regulators of Cdc25A , 2016, Cell Discovery.

[12]  John G Doench,et al.  Genetic screens and functional genomics using CRISPR/Cas9 technology , 2015, The FEBS journal.

[13]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[14]  T. Pierson,et al.  A CRISPR screen defines a signal peptide processing pathway required by flaviviruses , 2016, Nature.

[15]  J. Lukas,et al.  E2F-dependent accumulation of hEmi1 regulates S phase entry by inhibiting APCCdh1 , 2002, Nature Cell Biology.

[16]  Eugen C. Buehler,et al.  Common Seed Analysis to Identify Off-Target Effects in siRNA Screens , 2012, Journal of biomolecular screening.

[17]  A. Brass,et al.  Identification of Zika Virus and Dengue Virus Dependency Factors using Functional Genomics. , 2016, Cell reports.

[18]  Serban Nacu,et al.  Fast and SNP-tolerant detection of complex variants and splicing in short reads , 2010, Bioinform..

[19]  C. Antczak,et al.  An arrayed genome-scale lentiviral-enabled short hairpin RNA screen identifies lethal and rescuer gene candidates. , 2013, Assay and drug development technologies.

[20]  Anastasia Khvorova,et al.  3′ UTR seed matches, but not overall identity, are associated with RNAi off-targets , 2006, Nature Methods.

[21]  R. König,et al.  A probability-based approach for the analysis of large-scale RNAi screens , 2007, Nature Methods.

[22]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[23]  D. Durocher,et al.  High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities , 2015, Cell.

[24]  Randall W. King,et al.  A Bioinformatics Method Identifies Prominent Off-targeted Transcripts in RNAi Screens , 2012, Nature Methods.

[25]  J. Doudna,et al.  A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity , 2012, Science.

[26]  E. Lander,et al.  Identification and characterization of essential genes in the human genome , 2015, Science.

[27]  M. DePamphilis,et al.  Selective killing of cancer cells by suppression of geminin activity. , 2009, Cancer research.

[28]  Yilong Li,et al.  Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library , 2013, Nature Biotechnology.

[29]  Ling Qi,et al.  A CRISPR-Based Screen Identifies Genes Essential for West-Nile-Virus-Induced Cell Death. , 2015, Cell reports.

[30]  Liying Yan,et al.  TRAIP is involved in chromosome alignment and SAC regulation in mouse oocyte meiosis , 2016, Scientific Reports.

[31]  T. Golub,et al.  Genomic Copy Number Dictates a Gene-Independent Cell Response to CRISPR/Cas9 Targeting. , 2016, Cancer discovery.

[32]  P. Meraldi,et al.  TRAIP is a regulator of the spindle assembly checkpoint , 2014, Journal of Cell Science.

[33]  R. Bernards,et al.  CRISPR knockout screening outperforms shRNA and CRISPRi in identifying essential genes , 2016, Nature Biotechnology.

[34]  Tobias Schmidt,et al.  Synthesis of an arrayed sgRNA library targeting the human genome , 2015, Scientific Reports.

[35]  M. DePamphilis,et al.  Identification of genes that are essential to restrict genome duplication to once per cell division , 2016, Oncotarget.